Press

PanGenomic Health Provides Corporate Update

Mar 3 • 3 min read

PanGenomic Health Inc. (CSE: NARA), is pleased to provide a corporate update on its strategic initiatives. Acquisition of Mindleap Health Inc. In December 2022, the Company completed the acquisition of Mindleap Health Inc. (“Mindleap”) and its Mindleap app (the “Mindleap App”). The Mindleap App is a virtual health and inner wellness platform that supports its users’…

PharmAla Biotech named Exclusive MDMA Supply Partner to Awakn Life Sciences

Mar 3 • 3 min read

PharmAla Biotech Holdings Inc.(CSE: MDMA), a biotechnology company focused on the research, development, and manufacturing of MDXX class molecules (including MDMA) are pleased to announce that PharmAla has been named the exclusive MDMA supplier to Awakn LS Europe Holdings Limited (CSE:AWKN). “We’ve been working with the Awakn team for several months now, to ensure they…

Incannex Engages Catalent for Development and cGMP Manufacture of Psilocybin Drug Product for Clinical Trials and Potential Commercial Use

Mar 3 • 3 min read

Incannex Healthcare Limited (Nasdaq: IXHL | ASX: IHL), a pharmaceutical company developing proprietary medicinal cannabinoid products and psychedelic medicine therapies for unmet medical needs, is pleased to announce that it has engaged Catalent (‘Catalent’) to develop and manufacture a cGMP-grade psilocybin drug product for: (1) use in Incannex’s proprietary psilocybin-assisted psychotherapy drug development program and…

GH Research Reports Full Year 2022 Financial Results and Provides Business Updates

Mar 3 • 6 min read

GH Research PLC (Nasdaq: GHRS), a clinical-stage biopharmaceutical company dedicated to transforming the treatment of psychiatric and neurological disorders, today reported financial results for the full year ended December 31, 2022 and gave updates on its business. Business Updates We are pleased to report that we have recently initiated our multi-center, randomized, double-blind, placebo-controlled Phase…

COMPASS Pathways to participate in upcoming Cowen 43rd Annual Health Care Conference, Oppenheimer 33rd Annual Healthcare Conference, and Loop Capital Investor Conference

Mar 3 • 2 min read

COMPASS Pathways plc (Nasdaq: CMPS), a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that management will participate in three upcoming events as follows: Live audio webcast of the panel and presentation will be accessible from the “Events” page of the Investors section of the COMPASS…

Pages: 123456789101112131415161718192021222324252627282930313233343536373839404142434445464748495051525354555657585960616263646566676869707172737475767778798081828384858687888990919293949596979899100101102103104105106107108109110111112113114115116117118119120121122123124125126127128129130131132133134135136137138139140141142143144145146147148149150151152153154155156157158159160161162163164165166167168169170171172173174175176177178179180181182183184185186187188189190191192193194195196197198199200201202203204205206207208209210211212213214215216217218219220221222223224225226227228229230231232233234235236237238239240241242243244245246247248249250251252253254255256257258259260261262263264265266267268269270271272273274275276277278279280281282283284285286287288289290291292293294295296297298299300301302303304305306307308309310311312313314315316317318319320321322323324325326327328329330331332333334335336337338339340341342343344345346347348349350351352353354355356357358359360361362363364365366367368369370371372373374375376377378379380381382383384385386387388389390391392393394395396397398399400401402403404405406407408409410411412413414415416417418419420421422423424425426427428429430431432433434435436437438439440441